Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Mouthwash for COVID-19 Viral Load
NCT07068282Phase 1Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vitamin d in coronavirus disease 2019 (COVID-19), sponsored by King Faisal Specialist Hospital and Research Centre. Primary endpoint: No effect of D3 mouthwash on saliva of COVID-19 patients. Started Jul 2024; status: completed.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07068282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07068282.